Skip to main content

Drugmakers Turn to Data Mining to Avoid Expensive, Lengthy Drug Trials

By The Wall Street Journal  
   December 24, 2019

For drug companies, the use of real-world data can cut costs and shorten drug-development times. Instead of finding trial subjects, companies simply mine hospital and doctor files for cases where patients already took a drug in routine medical care, looking for changes in blood pressure, tumor size and other readings to see if the medicine is helping or causing a side effect.

Full story


Get the latest on healthcare leadership in your inbox.